Public health advocates have expressed alarm over the Trump administration's appointments to the Environmental Protection Agency's Science Advisory Committee on Chemicals (SACC). They allege that many of the new members have financial ties to the chemical industry, potentially compromising the committee's impartiality in reviewing toxic chemical research.
Critics argue that these appointments could undermine public health protections by providing a scientific basis for deregulation. The coalition of advocacy groups has highlighted specific nominees, including Michael Dourson, who have histories of industry alignment, raising questions about the integrity of the SACC's future assessments.
Watch for potential legal challenges from public health advocates regarding the SACC's composition. The implications of these appointments could affect future chemical regulations and public health standards, especially as the committee reviews critical toxic substances.